Learn more

SUZHOU RIBO LIFE SCIENCE CO LTD

Overview
  • Total Patents
    122
  • GoodIP Patent Rank
    16,603
About

SUZHOU RIBO LIFE SCIENCE CO LTD has a total of 122 patent applications. Its first patent ever was published in 2008. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are GLEAVE MARTIN, BUDDHIST TZU CHI MEDICAL FOUND and COSMA MARIA PIA.

Patent filings per year

Chart showing SUZHOU RIBO LIFE SCIENCE CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhang Hongyan 101
#2 Gao Shan 73
#3 Kang Daiwu 58
#4 Liang Zicai 16
#5 Cao Liqiang 13
#6 Yang Zhiwei 11
#7 Xi Zhen 9
#8 Huang Jinyu 9
#9 Chen Gengrong 9
#10 Wan Liangyi 7

Latest patents

Publication Filing date Title
WO2021037205A1 Compound and drug conjugate, and preparation method and use thereof
WO2020233650A1 Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
WO2020233651A1 Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
WO2020238763A1 Nucleic acid, pharmaceutical composition and conjugate, preparation method and use
WO2020233680A1 Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
WO2020238766A1 Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
WO2020233655A1 Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
WO2020238758A1 Nucleic acid, pharmaceutical composition and conjugate, preparation method therefor and use thereof
CN111979237A Nucleic acid, pharmaceutical composition containing nucleic acid, siRNA conjugate, preparation method and application
CN111973617A Nucleic acid, pharmaceutical composition and conjugate, preparation method and application
CN111973618A Nucleic acid, pharmaceutical composition and siRNA conjugate, preparation method and application
CN111973619A Nucleic acid, pharmaceutical composition containing nucleic acid, siRNA conjugate, preparation method and application
WO2020147847A1 Nucleic acid, composition and conjugate containing nucleic acid, preparation method, and use
WO2020135673A1 Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof
WO2020135581A1 Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof
WO2020063198A1 Sirna conjugate, preparation method therefor and use thereof
WO2020038377A1 Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, and use thereof
CN112007040A Combined medicine for treating viral hepatitis B
CN111378659A Nucleic acid for inhibiting STAT3 gene expression, pharmaceutical composition containing nucleic acid and application of pharmaceutical composition
CN111377985A Compounds and conjugates and methods of making and using the same